[Drug-induced lipidosis: formation of myeloid bodies (author's transl)].
D000818:Animals; D004048:Diethylamines; D004983:Ethanolamines; D005732:Gangliosides / Q000378:metabolism; D000882:Haplorhini; D006589:Hexestrol; D006801:Humans; D002479:Inclusion Bodies / Q000378:metabolism* / Q000648:ultrastructure; D007962:Leukocytes / Q000648:ultrastructure; D050356:Lipid Metabolism; D008064:Lipidoses / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D008099:Liver / Q000378:metabolism; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D010743:Phospholipids / Q000378:metabolism; D051381:Rats; D012270:Ribosomes; D013148:Spironolactone; D013154:Spleen / Q000378:metabolism; D014308:Triparanol / Q000009:adverse effects
D004048:Diethylamines; D004983:Ethanolamines; D005732:Gangliosides; D010743:Phospholipids; D006589:Hexestrol; D013148:Spironolactone; D014308:Triparanol